Literature DB >> 21909940

Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy.

Y Zhang1, S R Reng, L Wang, L Lu, Z H Zhao, Z K Zhang, X D Feng, X D Ding, J Wang, G Feng, T Z Dai, J Pu, X B Du.   

Abstract

The aim of this study was to evaluate the expression of Y-box binding protein-1 (YB-1) in nonneoplastic cervical tissue and cervical cancer tissue and to evaluate its relationship with chemoradiosensitivity in the cases of cervical cancer. We performed immunohistochemical studies to examine YB-1 expression among 59 patients with cervical cancer, 30 with cervical intraepithelial neoplasia (CIN), and 30 with cervicitis. The mean YB-1 histological score(HSCORE)values for cervicitis, cervical CIN, and cervical cancer tissues were 22.3, 39, and 84.4, respectively. The mean YB-1 HSCORE value was 80.0 for cervical cancer patients who showed complete pathological response to chemoradiotherapy and 144.3 for cervical cancer patients who showed partial pathological response. Our data showed that the YB-1 expression was the highest in cervical cancer tissue, followed by cervical CIN tissue, and then cervicitis tissues. High YB-1 expression resulted in a lower pathological response rate in patients of cervical cancer than low YB-1 expression did. Our results implied that YB-1 may play a role in the genesis of cervical cancer and that high YB-1 expression decreases the chemoradiosensitivity of cervical cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909940     DOI: 10.1007/s12032-011-0062-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  38 in total

1.  The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer.

Authors:  V Evdokimova; P Ruzanov; H Imataka; B Raught; Y Svitkin; L P Ovchinnikov; N Sonenberg
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 2.  The pleiotropic functions of the Y-box-binding protein, YB-1.

Authors:  Kimitoshi Kohno; Hiroto Izumi; Takeshi Uchiumi; Megumi Ashizuka; Michihiko Kuwano
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

3.  Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells.

Authors:  Tetsuji Tanaka; Tao Bai; Kazunori Yukawa; Tomoko Utsunomiya; Naohiko Umesaki
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

Review 4.  Gene regulation by Y-box proteins: coupling control of transcription and translation.

Authors:  K Matsumoto; A P Wolffe
Journal:  Trends Cell Biol       Date:  1998-08       Impact factor: 20.808

5.  Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.

Authors:  R C Bargou; K Jürchott; C Wagener; S Bergmann; S Metzner; K Bommert; M Y Mapara; K J Winzer; M Dietel; B Dörken; H D Royer
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

6.  Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.

Authors:  Joyce Wu; Cathy Lee; Daniel Yokom; Helen Jiang; Maggie C U Cheang; Erika Yorida; Dmitry Turbin; Isabelle M Berquin; Peter R Mertens; Thomas Iftner; C Blake Gilks; Sandra E Dunn
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  Twist promotes tumor cell growth through YB-1 expression.

Authors:  Masaki Shiota; Hiroto Izumi; Takamitsu Onitsuka; Naoya Miyamoto; Eiji Kashiwagi; Akihiko Kidani; Akira Yokomizo; Seiji Naito; Kimitoshi Kohno
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  An in vitro multistep carcinogenesis model for human cervical cancer.

Authors:  Mako Narisawa-Saito; Yuki Yoshimatsu; Shin-ichi Ohno; Takashi Yugawa; Nagayasu Egawa; Masatoshi Fujita; Setsuo Hirohashi; Tohru Kiyono
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.

Authors:  Cathy Lee; Jaspreet Dhillon; Michelle Y C Wang; Yuanyuan Gao; Kaiji Hu; Eugene Park; Arezoo Astanehe; Mien-Chie Hung; Peter Eirew; Connie J Eaves; Sandra E Dunn
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

10.  Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.

Authors:  Mahmoud Toulany; Tim-Andre Schickfluss; Wolfgang Eicheler; Rainer Kehlbach; Birgit Schittek; H Peter Rodemann
Journal:  Breast Cancer Res       Date:  2011-03-10       Impact factor: 6.466

View more
  5 in total

1.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  The expression level and prognostic value of Y-box binding protein-1 in rectal cancer.

Authors:  Yu Zhang; Ping-Wu Zhao; Gang Feng; Gang Xie; An-Qun Wang; Yong-Hong Yang; Dong Wang; Xiao-Bo Du
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

3.  Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.

Authors:  Shayan Khozooei; Konstanze Lettau; Francesca Barletta; Tina Jost; Simone Rebholz; Soundaram Veerappan; Mirita Franz-Wachtel; Boris Macek; George Iliakis; Luitpold V Distel; Daniel Zips; Mahmoud Toulany
Journal:  J Exp Clin Cancer Res       Date:  2022-08-22

Review 4.  A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.

Authors:  Akram Alkrekshi; Wei Wang; Priyanka Shailendra Rana; Vesna Markovic; Khalid Sossey-Alaoui
Journal:  Cell Signal       Date:  2021-07-03       Impact factor: 4.850

5.  Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer.

Authors:  Yun-Xia Zhang; Yan-Li Zhao
Journal:  Comput Math Methods Med       Date:  2016-02-29       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.